Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
Brookfield Corporation (BN): Analyst Targets Suggest Potential +39% Gain to $53

Brookfield Corporation (BN): Analyst Targets Suggest Potential +39% Gain to $53

Key Takeaways

  • The central target of $53 is the arithmetic mean of eight individually verified analyst price targets, rounded from roughly $52.60, and implies about a 39% gain from the latest price near $38.
  • Published targets are unusually wide, from $31 (one Sell-rated analyst) to $61 (RBC Capital and TD Cowen), signaling genuine disagreement about Brookfield's valuation.
  • The latest verified price is about $38.03, leaving the shares well below the central target and near the bottom of their 52-week range.
  • Supporting factors include a broadly bullish analyst stance, Brookfield's diversified real-assets franchise, and a large stake in its separately listed asset manager.
  • The biggest risks are rich headline valuation multiples, mark-to-market earnings volatility, and sensitivity to interest rates, credit spreads, and exit markets.
  • For more on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore these dedicated pages.

Analyst Consensus and Price Targets

Brookfield Corporation (BN), the Toronto-headquartered global owner and operator of real assets spanning infrastructure, renewable power, real estate, private equity, and credit, carries a broadly bullish sell-side posture. Across eight individually verified targets reviewed for this analysis, the range runs from $31 to $61, with a calculated mean of about $52.60, rounded to a central target of $53. I also checked comparable names using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent targets and actions include Morgan Stanley maintaining Buy while trimming its target from $59 to $54 (October 2026); Goldman Sachs cutting from $56 to $54 (August 2026); RBC Capital and TD Cowen both reiterating $61; J.P. Morgan at $56; BMO Capital at $51; and Scotiabank at $53. One Sell-rated analyst carries the $31 figure, which sits below the current price. The overall published mean across 11 analysts tracked by S&P Global is approximately $53.75, with a consensus rating of Buy.

The spread between $31 and $61 is wide, so the central target should be read as a midpoint of informed opinion rather than a precise forecast. Analysts generally argue Brookfield's portfolio of hard assets and its ownership stake in its separately listed asset manager are not fully reflected in the current share price, while the cautious view emphasizes valuation and mark-to-market complexity.

Current Market Position and Path Toward the Target

With the shares near $38.03, reaching $53 would require an advance of roughly 39% — a substantial move by any standard. The stock trades near the lower end of its 52-week range of $35.61 to $49.57, after a decline of about 21% through much of 2026.

A path toward the target would likely depend on a combination of stronger distributable earnings, improved realizations in private equity and credit, a re-rating of the asset-management stake, and a more supportive backdrop for long-duration and leveraged assets. Brookfield's reported earnings are heavily influenced by mark-to-market and consolidation effects, so headline results can swing materially from quarter to quarter. Its next earnings report is scheduled for November 12, 2026.

Factors That Could Support a Move Toward the Target

Brookfield's franchise breadth is a core support: diversified infrastructure and renewable-power assets tend to generate relatively stable, inflation-linked cash flows, while the insurance and credit businesses have grown. The company retains a substantial economic stake in its separately listed asset manager, Brookfield Asset Management (BAM), which many analysts view as underappreciated within the holding-company structure. Falling long-term interest rates or narrowing credit spreads would typically support asset valuations, while robust exit markets would help crystallize carried interest and realization gains. Analyst revisions, though recently mixed with several small target cuts, remain predominantly Buy-rated.

Factors That Could Prevent Reaching the Target

The principal obstacles are valuation and leverage. The trailing P/E (price-to-earnings) ratio is elevated — in the high-60s to low-70s — reflecting earnings that are compressed by mark-to-market adjustments, while a beta near 1.8 means the stock has historically fallen harder than the market in risk-off periods. A meaningful portion of Brookfield's debt sits at the asset level in non-recourse structures, but refinancing remains sensitive to long-term rates and credit spreads. The office and retail real estate books remain the least liquid segments, and a prolonged slowdown in transaction and exit markets would delay realization income. The lone $31 target illustrates that a genuinely cautious case exists.

Technical Levels and Market Structure

The shares sit near a 52-week low of $35.61, which represents the clearest near-term support level. On the upside, prior congestion between roughly $42 and $45, followed by the 52-week high of $49.57, marks key resistance zones the stock would need to reclaim before a move toward $53 becomes technically plausible. The long-term trend remains under pressure after the 2026 decline, with the shares trading below longer-term moving averages, so any sustained advance would require a change in trend structure rather than a brief bounce.

Time Horizon and Key Items to Monitor

Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ. Investors weighing the $53 target should watch the November 12, 2026 earnings release and guidance, particularly distributable earnings, fee-related earnings at the asset manager, and any commentary on realizations and fundraising. Beyond earnings, the most relevant items are interest-rate decisions from the Federal Reserve, credit-spread movements, transaction activity in private equity and credit, insurance-segment performance, and any changes to analyst targets, which have been drifting modestly lower in some cases.

Using AI Daily Buy/Sell Signals in My Process

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find this tool helpful for flagging momentum shifts in names like Brookfield without replacing deeper fundamental work. It complements the analyst targets by highlighting when market structure starts to align with or diverge from the broader consensus view.

Final Assessment

Can Brookfield Corporation (BN) stock reach $53? The central target — the mean of eight verified analyst targets, with the full range spanning $31 to $61 — implies a roughly 39% move from the current price near $38, which is substantial. The case rests on Brookfield's diversified real-assets franchise, its stake in the listed asset manager, and a predominantly Buy-rated analyst base. The counterarguments are equally real: elevated headline valuation multiples, mark-to-market earnings volatility, interest-rate and credit sensitivity, and a technical picture still weighed down by the 2026 decline. The wide analyst range underscores that this is a genuinely contested stock, and the answer will hinge on earnings execution, transaction markets, and the interest-rate environment rather than any single data point. No outcome is guaranteed.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BN

BN in +3.86% Uptrend, growing for three consecutive days on October 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BN advanced for three days, in 225 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

BN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.

The Aroon Indicator entered an Uptrend today. In 149 of 270 cases where BN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Bearish Trend Analysis

The 10-day RSI Indicator for BN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 23 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BN as a result. In 44 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.

The Moving Average Convergence Divergence Histogram (MACD) for BN turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 27 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

BN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. BN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.174) is normal, around the industry mean (2.423). BN has a moderately high P/E Ratio (73.893) as compared to the industry average of (8.341). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.318). Dividend Yield (0.007) settles around the average of (0.274) among similar stocks. P/S Ratio (1.135) is also within normal values, averaging (15.906).

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD Idea Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.92B. The market cap for tickers in the group ranges from 1.6 to 182.57B. BLK holds the highest valuation in this group at 182.57B. The lowest valued company is OXLCO at 1.6.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was -5%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -6%. ICMB experienced the highest price growth at 66%, while OXSQ experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 58
Price Growth Rating: 57
SMR Rating: 67
Profit Risk Rating: 81
Seasonality Score: 16 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an alternative asset manager which owns, manages and operates real estate, financial and power generation related businesses

Industry InvestmentManagers

Industry
Investment Managers
Address
181 Bay Street
Phone
+1 416 363-9491
Employees
257300
Web
https://www.brookfield.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.